139 related articles for article (PubMed ID: 15705862)
1. Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose.
Moadel RM; Weldon RH; Katz EB; Lu P; Mani J; Stahl M; Blaufox MD; Pestell RG; Charron MJ; Dadachova E
Cancer Res; 2005 Feb; 65(3):698-702. PubMed ID: 15705862
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer.
Moadel RM; Nguyen AV; Lin EY; Lu P; Mani J; Blaufox MD; Pollard JW; Dadachova E
Breast Cancer Res; 2003; 5(6):R199-205. PubMed ID: 14580255
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer Positron Emission Tomography Imaging Study in Mice.
Wuest M; Hamann I; Bouvet V; Glubrecht D; Marshall A; Trayner B; Soueidan OM; Krys D; Wagner M; Cheeseman C; West F; Wuest F
Mol Pharmacol; 2018 Feb; 93(2):79-89. PubMed ID: 29142019
[TBL] [Abstract][Full Text] [Related]
4. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
Hamann I; Krys D; Glubrecht D; Bouvet V; Marshall A; Vos L; Mackey JR; Wuest M; Wuest F
FASEB J; 2018 Sep; 32(9):5104-5118. PubMed ID: 29913554
[TBL] [Abstract][Full Text] [Related]
6. Positron emitting 18F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy.
Mortimer JE; Taylor ME
Breast Cancer Res; 2003; 5(6):329-31. PubMed ID: 14580251
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of positron emission tomography/fluorescence dual imaging probes for targeting facilitated glucose transporter 1 (GLUT1).
Yuen R; Wagner M; Richter S; Dufour J; Wuest M; West FG; Wuest F
Org Biomol Chem; 2021 Apr; 19(14):3241-3254. PubMed ID: 33885579
[TBL] [Abstract][Full Text] [Related]
8. Lactate-induced translocation of GLUT1 and GLUT4 is not mediated by the phosphatidyl-inositol-3-kinase pathway in the rat heart.
Medina RA; Southworth R; Fuller W; Garlick PB
Basic Res Cardiol; 2002 Mar; 97(2):168-76. PubMed ID: 12002265
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.
Chung JK; Lee YJ; Kim C; Choi SR; Kim M; Lee K; Jeong JM; Lee DS; Jang JJ; Lee MC
J Nucl Med; 1999 Feb; 40(2):339-46. PubMed ID: 10025844
[TBL] [Abstract][Full Text] [Related]
10. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
11. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
[TBL] [Abstract][Full Text] [Related]
12. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Brown RS; Leung JY; Fisher SJ; Frey KA; Ethier SP; Wahl RL
J Nucl Med; 1996 Jun; 37(6):1042-7. PubMed ID: 8683298
[TBL] [Abstract][Full Text] [Related]
15. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
16. Expression of glucose transporters in human peritoneal mesothelial cells.
Schröppel B; Fischereder M; Wiese P; Segerer S; Huber S; Kretzler M; Heiss P; Sitter T; Schlöndorff D
Kidney Int; 1998 May; 53(5):1278-87. PubMed ID: 9573543
[TBL] [Abstract][Full Text] [Related]
17. Glucose transporter GLUT8 translocation in neurons is not insulin responsive.
Shin BC; McKnight RA; Devaskar SU
J Neurosci Res; 2004 Mar; 75(6):835-44. PubMed ID: 14994344
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
Brown RS; Wahl RL
Cancer; 1993 Nov; 72(10):2979-85. PubMed ID: 8221565
[TBL] [Abstract][Full Text] [Related]
19. High and polarized expression of GLUT1 glucose transporters in epithelial cells from mammary gland: acute down-regulation of GLUT1 carriers by weaning.
Camps M; Vilaro S; Testar X; Palacín M; Zorzano A
Endocrinology; 1994 Feb; 134(2):924-34. PubMed ID: 8299587
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]